The Lock and Key of Medicine : Monoclonal Antibodies and the Transformation of Healthcare /

Saved in:
Bibliographic Details
Author / Creator:Marks, Lara, 1963- author.
Imprint:New Haven [Connecticut] ; London : Yale University Press, [2015]
©2015
Description:1 online resource : illustrations
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11675867
Hidden Bibliographic Details
ISBN:9780300213522
0300213522
9780300167733
0300167733
Notes:Includes bibliographical references and index.
Vendor-supplied metadata.
Summary:The untold story of monoclonal antibodies-the molecular heroes of biotechnology that revolutionized the diagnosis and treatment of more than fifty major diseases This book is the first to tell the extraordinary yet unheralded history of monoclonal antibodies. Often referred to as Mabs, they are unfamiliar to most nonscientists, yet these microscopic protein molecules are everywhere, quietly shaping our lives and healthcare. Discovered in the mid-1970s in the laboratory where Watson and Crick had earlier unveiled the structure of DNA, Mabs have radically changed understandings of the pathways of disease. They have enabled faster, cheaper, and more accurate clinical diagnostic testing on a vast scale. And they have played a fundamental role in pharmaceutical innovation, leading to such developments as recombinant interferon and insulin, and personalized drug therapies such as Herceptin. Today Mabs constitute six of the world's top ten blockbuster drugs and make up a third of new introduced treatments. Lara V. Marks recounts the risks and opposition that a daring handful of individuals faced while discovering and developing Mabs, and she addresses the related scientific, medical, technological, business, and social challenges that arose. She offers a saga of entrepreneurs whose persistence and creativity ultimately changed the healthcare landscape and brought untold relief to millions of patients. Even so, as Marks shows, controversies over Mabs remain, and she examines current debates over the costs and effectiveness of these innovative drugs.
Review by Choice Review

Modern medical biotechnology springs from attempts to find the magic bullets for diagnosing and treating disease. One of the earliest potential miracle diagnostic and therapeutic technologies was monoclonal antibodies. The history of this technology, like that of many medical discoveries, is awash with failures as well as successes--and it was equally hailed and condemned by the bioethics and medical communities. This not a technical tome about monoclonal antibodies. Rather, Marks (history of medicine, King's College London and Cambridge Univ., UK) presents monoclonal antibodies as a model of modern medical discovery using innovative molecular biology techniques. She begins with a brief yet comprehensive synopsis of how the development of monoclonal antibodies in 1976 redirected the focus for innovations in medical diagnosis and therapy. In the subsequent chapters she describes the history of monoclonal antibodies step by step, providing engaging accounts of the researchers and corporations that exploited the benefits of monoclonal antibodies. Marks avoids, as much as possible, technical jargon, and she uses common terms to explain the technical material. The book culminates with two chapters describing the most successful monoclonal antibody applications and the future directions in monoclonal antibody research. Marks includes references to ample primary sources. Summing Up: Highly recommended. Lower-division undergraduates, including two-year programs, through practitioners; general readers. --Brian R. Shmaefsky, Lone Star College - Kingwood

Copyright American Library Association, used with permission.
Review by Choice Review